Your browser doesn't support javascript.
loading
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC: Findings From a Global Named Patient Use Program.
Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; Shih, Jin-Yuan; Liao, Wei-Yu; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; Yang, James Chih-Hsin; Lorence, Robert M; Carrière, Philippe; Cseh, Agnieszka; Chang, Gee-Chen.
Afiliação
  • Peters S; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.
  • Curioni-Fontecedro A; Department of Hematology and Oncology, Division of Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Nechushtan H; Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Kiryat Hadassah, Jerusalem, Israel.
  • Shih JY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Liao WY; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Gautschi O; Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
  • Spataro V; Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Unk M; Department for Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Yang JC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Lorence RM; Oncology Research, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
  • Carrière P; Risk Management Oncology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
  • Cseh A; Medical Department, Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria.
  • Chang GC; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
J Thorac Oncol ; 13(12): 1897-1905, 2018 12.
Article em En | MEDLINE | ID: mdl-30096481
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia de Salvação / Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Afatinib / Neoplasias Pulmonares / Mutação / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia de Salvação / Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Afatinib / Neoplasias Pulmonares / Mutação / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article